Are you sure you want to hide the widget forever? If you need it back, please clear your cookies.
Content
Colors
Color Filters
Navigation
Selected Language
English (United States)
All Languages
Accessibility Statement
Our Commitment to Accessibility
We are committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone, and applying the relevant accessibility standards to help users with various disabilities access our website effectively.
Compliance Status
Our website strives to conform to the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA standards. We also aim to be compliant with the Americans with Disabilities Act (ADA) and the European Accessibility Act requirements. These guidelines and regulations explain how to make web content more accessible to people with a wide range of disabilities. We acknowledge that some aspects of our website may not yet achieve full compliance, and we are actively working to address these areas.
Accessibility Features Available
Our website implements the Accessibly App, which provides a variety of tools to enhance website accessibility:
Visual Adjustments
Bigger Text: Increase text size up to 3x for better readability (WCAG 2.1/1.4.4)
Bigger Cursor: Enhanced cursor visibility for easier navigation
Color Adjustments: Invert colors, adjust contrast, brightness, and saturation
Grayscale Mode: Convert website to grayscale for users with visual impairments
Hide Images: Reduce visual distractions for easier reading
Reading and Navigation Aids
Reading Line: Adds a guide line to help follow text
Reading Mask: Places a mask over text to isolate lines and enhance focus
Readable Fonts: Converts to highly legible fonts for better comprehension
Highlight Links: Makes links more prominent for easier navigation
Dyslexic Fonts: Special typography for users with dyslexia
Page Structure: Simplified layout options for easier navigation
Assistive Technologies
Keyboard Navigation: Full website control using keyboard (Tab, Shift+Tab, Enter)
Alt Text for Images: AI-generated image descriptions where manual ones aren't provided
Read Page Aloud: Text-to-speech functionality
Stop Animations: Pause motion content for users with vestibular disorders
Limitations and Feedback
Despite our best efforts to ensure accessibility, there may be some limitations. Content provided by third parties, user-generated content, or certain legacy pages may not be fully accessible. We are continuously working to improve our website's accessibility.
We welcome your feedback on the accessibility of our website. If you encounter any barriers or have suggestions for improvement, please contact us. We are committed to addressing these issues promptly.
Technical Information
The accessibility features on this website are provided through the Accessibly App, which utilizes several technologies including HTML, CSS, JavaScript, and various frameworks to enhance accessibility. Our implementation strives to be compatible with major screen readers and assistive technologies.
Legal Disclaimer
While we strive to adhere to WCAG 2.1 Level AA standards and provide accessible content, we cannot guarantee that our website will be accessible to all users under all circumstances. This website is provided 'as is' without any representations or warranties, express or implied.
In no event shall we be liable for any damages arising from or related to:
Inability to access or use the website
Any alleged non-compliance with accessibility laws or regulations
Any disruption or errors in the functionality of accessibility features
By using this website, you agree to hold us harmless from any claims related to website accessibility issues. We are committed to addressing accessibility barriers in good faith but cannot guarantee immediate resolution in all cases.
Contact Us
If you have any questions about our accessibility efforts or encounter any barriers while using our website, please contact us.
Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
A Black-owned farm in Florida received a cannabis license for the first time, German officials are looking to California for cannabis industry inspo, and Sen. Booker made a case for federal legalization.
Let’s dive into this week’s cannanews.
Gwinn Brothers Beat Florida’s Rigid Application Process
After years of delays, Florida finally awarded its first Black farmer commercial cannabis license. The lucky recipients are Robert and Clifford Gwinn from Gwinn Brothers Farms. The Gwinns are joining the ranks of the 22 current commercial cannabis license holders—many of which are giant multi-state corporations.
The special “Black farmer commercial cannabis license” came into existence in 2017. Regulations mandated that the license be set aside for the Black farmers involved in the landmark 1997 Pigford v. Glickman case. The case saw thousands of Black farmers successfully sue the U.S. Department of Agriculture over its discriminatory loan allocation practices.
Unfortunately, this was not the end of the troubles experienced by Florida’s Black farmers. Last year, the application fee for the Black farmer commercial license—dubbed the “Pigford license”—was raised to $146,000. For comparison, the application fee for a standard commercial cannabis license is only $60,000.
Beyond these expensive fees, Florida’s strict commercial cannabis business guidelines create further issues. Florida mandates that cannabis companies handle all business from cultivation to distribution. This makes it all the more difficult for small businesses to obtain licenses without the help of wealthy investors.
All these factors make the Gwinns’ success story all the more impressive. We hope to see more Florida success stories like this in the future!
What do you think of Florida’s approach to cannabis? Do you think the state will ever be able to live up to its massive potential? Let us know in the comments!
See If You Qualify For Medical Marijuana -Select Your State!
Germany Sends Officials on California Canna-Trip
German officials are ramping up for legalization! The country’s latest move involved sending a group of lawmakers to sunny California. The group toured cannabis businesses across the state, hoping to gain some insight into how Germany should proceed with its cannabis legalization.
German lawmakers were reportedly most interested in assessing the “opportunities and risks” that come with legalization. Particularly, how social equity licenses worked in practice. As such, the group spent a lot of the trip visiting social equity-licensed dispensaries.
The group of German lawmakers met with California officials and cannabis industry stakeholders in Oakland. During the meeting, California officials emphasized the importance of creating a regulated environment that attracts consumers and producers while diverting business from the illicit market.
With the trip complete—German lawmakers will now put their full attention to legalizing the recreational use of cannabis in the following months. Check in with Veriheal to stay up to date with Germany’s journey to legalization.
What do you think of Germany’s California trip? Let us know in the comments!
Sen. Booker Breaks Down “Twin Crisis” of Federal Prohibition
Finally, New Jersey Sen. Cory Booker recently released a video stressing the need for federal legalization.
In the video, Booker points out the absurdity of continued federal cannabis prohibition given that “most states now have moved to legalize marijuana, whether it’s for medical use or for overall adult use.” This strange state of affairs, Booker states, has caused a “twin crisis.”
On one side, those living in cannabis-illegal states face the risk of being arrested for cannabis possession. On the other side, hopeful cannabis business owners in legal states are barred from traditional financial services. In both cases, communities of color are often the ones receiving the brunt of the damage. This makes true equity all the more difficult to achieve.
What do you think of Sen. Booker’s video? Would you like to see your representative take similar action? Let us know in the comments!
Mexico-born and California-raised, Cesar is a Marketing Associate at Veriheal. When he’s not scouring social media for the latest internet drama, you can find him working on yet another collage project.
Have you ever consumed cannabis and gotten a little too high for your liking? Or have you ever needed to calm down a friend who consumed too much weed for their tolerance level? If so, we’ve got you covered. Although an overdose (taking more than what is medically recommended) of delta-9 tetrahydrocannabinol (THC) is not…
Many pet owners seek holistic, alternative treatments beyond traditional medicine for their four-legged family members. CBD is becoming a popular holistic option for pet parents due to its wide range of therapeutic benefits and availability in both online and brick-and-mortar pet stores. In this article, you’ll learn how CBD affects pets, explore its potential benefits,…
Over the years, Hollywood has had a mixed relationship with cannabis. Portrayals have run the gamut from weed as the devil’s lettuce, able to ruin your life and destroy your mind after just a single puff, to a beneficial, life-giving MacGuffin. Because American audiences have such wide-ranging attitudes towards weed— according to the Pew Research…
You may think that when someone has a medical cannabis card, they are able to use cannabis however their medical practitioner sees fit. However, this is not always the case! Depending on someone’s employment and place of work, they may not be able to use cannabis, even if they were to obtain a medical cannabis…
In January, the US Food and Drug Administration (FDA) approved the Johnson & Johnson brand nasal spray, Spravato®, as the world’s first and only monotherapy for addressing treatment-resistant cases of major depressive disorder (MDD). In 2019, the FDA approved Spravato to treat treatment-resistant depression (TRD), with optional uses alone or alongside oral antidepressant medication (both…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.